Company Overview
Company Name
AVEO Oncology
Address
1 Marina Park Drive fl 12, Boston, MA, 02210, United States
Website
aveooncology.comPhone
(857) 400-0101Approx. Annual Revenue
$22.0M
Employees
120
Established
2011
About AVEO Oncology
Aveo Oncology is a biopharmaceutical company based in the United States. The company is focused on developing novel cancer treatments, including its lead product, tivozanib, which has received FDA approval for the treatment of metastatic renal cell carcinoma. Aveo Oncology's pipeline also includes other investigational therapies targeting various cancer types.
Business Profile
Read from the AVEO Oncology website on Oct 13, 2026. Hover an item to see the exact wording it came from.
About the website
- Website quality (AI-assessed)
- 7/10 · Current copyright 2025; Complete navigation and content
- Footer copyright year
- 2025
Biotech & Life Sciences Companies near Boston, MA
- EMD Seronoemdserono.com
- Inozyme Pharmainozyme.com
- Karuna Therapeuticskarunatx.com
- Atea Pharmaceuticalsateapharma.com
- Albireo Pharmaalbireopharma.com
- Holobiomeholobiome.org
- Akouosakouos.com
- CRISPR Therapeuticscrisprtx.com
- Amplitude Vascular Systemsavspulse.com
- Boston Immune Technologies & Therapeuticsbostonimmunetech.com
Frequently Asked Questions about AVEO Oncology
Categories
Technologies Used
Social Profiles
Key Decision Makers
Sarah R. Associate Director Clinical Operations